Cargando…

PI 3-kinase and disease

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Cantley, Lewis C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073074/ http://dx.doi.org/10.1186/2049-3002-2-S1-O30

Ejemplares similares

PI 3-kinase and disease
por: Cantley, Lewis C
Publicado: (2012)

Ritonavir inhibits NF-AT activation through modulation of the PI-3 kinase/Akt Ppathway
por: Pati, Shibani, et al.
Publicado: (2006)

Functional redundancy of PI3K isoforms in conventional T cells provides a selective Treg-targeting strategy through inhibition of PI3K-delta isoform
por: Ahmad, Shamim, et al.
Publicado: (2014)

Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
por: Locasale, Jason W, et al.
Publicado: (2012)

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
por: Bhatt, A, et al.
Publicado: (2009)

Mevalonate kinase deficiency: an early onset inflammatory bowel disease?
por: Martins, A, et al.
Publicado: (2015)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

PI3K-C2α regulates Polycystin-2 ciliary entry to prevent kidney cyst formation
por: Margaria, JP, et al.
Publicado: (2015)

The state of PI monotherapy and NRTI-sparing therapy
por: Arribas, JR
Publicado: (2010)

The role of activation of PERK in activating glycogen synthase kinase 3(GSK-3) by oleic acid(OA) in type 2 diabetes
por: Wu, Wei, et al.
Publicado: (2013)

Phase-Sensitive ChEmical Selection (PiSCES) method for fat signal removal in LGE
por: Janich, Martin A, et al.
Publicado: (2016)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

Redox regulation of protein kinase G
por: Eaton, Philip
Publicado: (2009)

Targeting of MuLV Gag to the plasma membrane is mediated by PI(4,5)P(2 )and PhosphatidylSerine
por: Hamard-Peron, E, et al.
Publicado: (2009)

cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013)

Control of initial steps of ciliogenesis by protein kinases
por: Carvalho, R, et al.
Publicado: (2015)

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
por: Pillay, D, et al.
Publicado: (2010)

The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003)

Mapping out the mitogen activated protein kinase pathway
por: Firestein, GS
Publicado: (2004)

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)

Rescue of cGMP kinase I and the cause of premature death
por: Hofmann, Franz, et al.
Publicado: (2009)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

Mechanisms of autoimmunity in mice lacking the mer membrane tyrosine kinase
por: Cohen, PL, et al.
Publicado: (2004)

Tau tubulin kinase 2 is required to initiate mammalian ciliogenesis
por: Goetz, S, et al.
Publicado: (2012)

The role of the cGMP-dependent protein kinase in development of the malaria parasite
por: McRobert, Louisa, et al.
Publicado: (2009)

Preliminary response to Janus kinase inhibition with baricitinib in chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE)
por: Montealegre, G, et al.
Publicado: (2015)

Cyclic GMP-dependent protein kinase regulation of airway smooth muscle in asthma
por: Myoishi, Masafumi, et al.
Publicado: (2009)

Regulation of cilium length and intraflagellar transport by the MAP kinases MAK, MRK, and MOK
por: Jansen, G, et al.
Publicado: (2012)

Redox signalling by protein kinase G Iα in cardiovascular physiology and pathology
por: Eaton, Philip
Publicado: (2013)

Phosphoinositide 3-Kinase regulates glycolysis through mobilization of Aldolase A from the actin cytoskeleton
por: Hu, Hai, et al.
Publicado: (2014)

cGMP-dependent kinase 2, Na(+)/H(+) regulatory factor 2, and Na(+)/H(+) exchanger isoform 3 assemble within lipid rafts in murine small intestinal brush border membrane
por: Luo, Min, et al.
Publicado: (2013)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Cyclic GMP-dependent protein kinase II promotes chondrocyte hypertrophy and skeletal growth
por: Kawaguchi, Hiroshi, et al.
Publicado: (2009)

Role of cGMP-dependent protein kinases for fear memory formation in the lateral amygdala
por: Paul, Cindy, et al.
Publicado: (2009)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: van Dijk, M.J., et al.
Publicado: (2023)

Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication
por: Dostmann, Wolfgang R, et al.
Publicado: (2011)

NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

S109: ACTIVATION OF PYRUVATE KINASE-R WITH ETAVOPIVAT (FT-4202) IS WELL TOLERATED, IMPROVES ANEMIA, AND DECREASES INTRAVASCULAR HEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE TREATED FOR UP TO 12 WEEKS
por: Telen, M, et al.
Publicado: (2022)

Presynaptic cGMP-dependent protein kinase-I mediates synaptic potentiation in spinal amplification of pain
por: Luo, Ceng, et al.
Publicado: (2009)

A role for cGMP-dependent protein kinase II in AMPA receptor trafficking and synaptic plasticity
por: Serulle, Yafelle, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7oj13th6sb894pq51kc58551mj